← Browse by Condition
Medical Condition

arrhythmogenic cardiomyopathy

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06174220 Phase 2
Recruiting

Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy

Enrollment
120 pts
Location
Canada
Sponsor
Hamilton Health Sciences Corpo...
View Trial →